Non-pyrogenic and sterile P-32-Sodium Phosphate Solution radiopharmaceutical with a half-life of 14.29 days is used for treatment of polycythemia vera, chronic myelocytic leukemia and chronic lymphocytic leukemia. This product is also approved by FDA. This radiopharmaceutical may also be used in the palliative treatment of patients with different areas of skeletal metastases.
Radiopharmaceutical
theragnostic
